We report maximized specific loss power and intrinsic loss power approaching theoretical limits for AC magnetic field heating of nanoparticles. This is achieved by engineering the effective magnetic anisotropy barrier of nanoparticles via alloying of hard and soft ferrites. 22 nm Co0.03Mn0.28Fe2.7O4/SiO2 NPs reached a specific loss power value of 3417 W/gmetal at a field of 33 kA/m and 380 kHz. Biocompatible Zn0.3Fe2.7O4/SiO2 nanoparticles achieved specific loss power of 500 W/gmetal and intrinsic loss power of 26.8 nHm 2 /kg at field parameters of 7 kA/m and 380 kHz, below the clinical safety limit. Magnetic bone cement achieved heating adequate for bone tumor hyperthermia, incorporating ultralow dosage of just 1 wt% of nanoparticles. In cellular hyperthermia experiments, these nanoparticles demonstrated high cell death rate at low field parameters. Zn0.3Fe2.7O4/SiO2 nanoparticles show cell viabilities above 97% at concentrations up to 500 µg/ml within 48 hrs, suggesting toxicity lower than that of magnetite.
Magnetic nanoparticles (NPs) have received great attention over the past several decades due to their potential biomedical applications in targeted drug delivery, biological separation, magnetoresistive bio-sensing, magnetic resonance imaging, and as heat dissipation agents in gene transcription, neural stimulation and cancer treatment. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Magnetic hyperthermia, first proposed by Gilchrist in 1957, [13] employs heat dissipation by magnetic NPs in an alternating current (AC) magnetic field to kill tumor cells. The design and synthesis of magnetic NPs should take into consideration the following constraints: first of all, they should have the highest possible specific loss power (SLP) within the field and frequency range deemed safe for human body to avoid potential side effects and to be useful for treatment of small tumors; [11] second, they should be close to superparamagnetic (SPM) with low magnetostatic interactions to avoid agglomeration; [14, 15] and third, they should be biocompatible with low cytotoxicity. [16] [17] [18] [19] Iron oxide NPs are the most commonly used materials in magnetic hyperthermia because of their low toxicity. [20] [21] [22] [23] Other ferrite NPs such as manganese ferrite, and more recently, zinc ferrite have also been explored due to their high magnetization among the ferrite family and stability against oxidation. [24, 25] Relatively high SLP values have been achieved by these NPs. [26] However, further increasing the SLP by increasing the saturation magnetization (MS) would be futile. Although a high MS is beneficial for increasing SLP, high MS materials are typically metallic and face stability and toxicity issues in physiological environment. [21] An alternative approach to maximizing the SLP is to tune the effective anisotropy of the NPs. For example, shape anisotropy can be used to increase SLP of iron oxide nanocubes. [20] Very large SLP has been obtained by tuning the anisotropy of NPs through hard-soft exchange-coupled core/shell NP approach. [27] However, they were achieved at high field amplitude and frequency values unsuitable for clinical applications. [27] In this work, we report the design and synthesis of monodisperse SPM NPs with maximized SLP and intrinsic loss power (ILP) at different field parameters. ILP is defined as SLP/H 2 f under linear response theory to compare the performance of NPs measured under different field parameters. [28] We first show that SLP can be maximized at H = 33 kA/m and f = 380 kHz, by alloying of hard cobalt ferrite and soft manganese ferrite to make CoxMn(0.3-x)Fe2.7O4, and tuning the size and composition of the mixed ferrite NPs. Unlike the core/shell approach, alloying allows convenient control of the effective anisotropy independent of NP size. A thin silica shell coating renders watersolubility and bio-functionality. [22] 22 nm Co0.03Mn0.28Fe2.7O4/SiO2 NPs reach a SLP value of 3417 W/gmetal. We further optimize the composition of biocompatible ZnxFe3-xO4 NPs for enhanced SLP under clinically safe field parameters (the product of field amplitude and frequency Hf < 510 9 A/(ms)). The Zn0.3Fe2.7O4 NPs achieved SLP and ILP values of 1010 W/gmetal and 15.7 nHm 2 /kg at H = 13 kA/m, 500 W/gmetal and 26.8 nHm 2 /kg at 7 kA/m, and 282 W/gmetal and 59.9 nHm 2 /kg at 3 kA/m, respectively (f = 380 kHz). Zn0.3Fe2.7O4/SiO2 NPs show no cytotoxicity after 48 hrs at concentrations up to 500 µg/ml. Using the optimized biocompatible NPs, we achieved comparable temperature rise with significant decrease in dosage in a model mimicking bone tumor hyperthermia. [29, 30] Cellular hyperthermia using 300 µg/ml Zn0.3Fe2.7O4/SiO2 NPs resulted in >89% cell death upon 10 min exposure to AC field of H= 13 kA/m and f = 380 kHz. Our designed biocompatible NP with maximized SLP and ILP provide a pathway towards targeted magnetic hyperthermia treatment of small tumors and metastases [11] , and rapid remote neural stimulation. [4] The mechanism of heat loss in magnetic hyperthermia is the energy dissipated during the magnetization reversal, and is therefore proportional to the product of the area of the AC magnetic hysteresis loop and the frequency. [31] An estimate of the upper limit of achievable SLP for ferrite NPs can be done as follows:
where is the saturation magnetization, the amplitude of the magnetic field,  the mass density of the NPs and the frequency .  is a dimensionless factor describing the deviation from a square hysteresis, which is related to the degree of alignment, and should also dependent on the types of effective anisotropy (uniaxial vs cubic) and inter-particle interactions. Using  =1 for aligned Stoner-Wohlfarth particles with uniaxial anisotropy, ~ 480 kA/m, = 33 kA/m,  ~ 5 g/cm 3 and f =380 kHz, SLP is estimated to be ~ 5000 W/gNP or ~ 7000 W/gmetal. Any value higher than that is likely non-physical. For completely random ensembles,  is reduced to 0.39. [31] Note here the optimal AC coercivity ( ) should be ~ 0.8 . The AC hysteresis area is maximized this way despite the fact that a fraction of the NPs cannot be switched [31] .  as high as 0.46 has been reported for magnetosomes aligned in an external field. [32] Thus the limit of SLP for any ferrite NPs at a field of 33 kA/m and 380 kHz is about ½*7000 ~ 3500 W/gmetal.
How can we then tune the properties of NPs to approach the theoretical limits? The key is to engineer the anisotropy energy barrier for magnetization reversal to match a specific field amplitude and frequency for a particular application. [4, [15] [16] [17] [18] According to the Stoner-Wohlfarth model, [33] the anisotropy barrier is proportional to KuV, where Ku is the uniaxial anisotropy constant and V is the volume of the magnetic grain, two critical parameters that can be tuned to maximize SLP. Ku and V together determine the temperature and frequency dependent coercivity ( ), and the shape of the AC hysteresis loop. Generally, at optimized effective anisotropy, a large NP size is preferred since MS increases slightly with increasing size, as long as it is not too large to accommodate multi-domain states which reduce . Practically, the NPs should be kept nearly SPM to avoid dipole interaction induced agglomeration. We therefore adopt the following strategy to maximize SLP at clinically relevant field parameters: should aim for a room temperature anisotropy field slightly higher than the field amplitude to achieve the highest SLP. [31] The metal composition is limited to (Co+Mn):Fe = 1:9 to minimize potential toxicity; 3. Maximize SLP and ILP at field parameters below the clinical safety limit (f = 380 kHz, H  13 kA/m and Hf < 510 9 A/(ms)). As the anisotropy field of magnetite is larger than the field amplitude, alloying with a soft ferrite such as MnxFe3-xO4 is needed. For future in vivo applications, however,
we choose zinc ferrite due to its bio-compatibility. Stoichiometric ZnFe2O4 is antiferromagnetic with low magnetization, while non-stoichiometric ZnxFe3-xO4 is a soft ferrite with MS moderately higher than that of Fe3O4 at low Zn content. [25] We thus tune its composition to maximize SLP and ILP at field amplitudes smaller than 13 kA/m.
All types of magnetic cores were synthesized by a modified one-pot thermal decomposition method. [12, 34] These NPs are monodisperse with narrow size distribution, as observed from transmission electron microscopy (TEM) images. Fig. 1(a) is the TEM image of 22 nm Mn0.3Fe2.7O4 NPs. NPs show well-defined facets, with polyhedral shape.
In our experiments, NPs from 7 nm up to 22 nm were investigated (Fig. S1 ), below which the NPs show SPM behavior. When the sizes are larger than 22 nm, Mn0.3Fe2.7O4
NPs become ferromagnetic and tend to agglomerate in the solution due to strong magnetostatic interactions. Therefore, they are excluded from further investigations. A silica shell was coated by reverse microemulsion method. [35] The TEM image of the 22-nm Mn0.3Fe2.7O4/SiO2 NPs is shown in Fig. 1 (b) . The silica shells were kept thin with a thickness of 4-5 nm to minimize possible temperature gradient in AC field heating. [22] The silica coating makes the NPs hydrophilic, leading to aqueous dispersions stable for years without agglomeration ( Fig. S2(a) ). As shown in Fig S2(b) , the zeta-potential of the NPs is about -30 mV. Negative charges on NP surface produces sufficient repulsive force to balance the magnetically induced attractive force to keep them from aggregation.
Within the core size range of 7 nm to 22 nm, the SLP of an aqueous dispersion of 1 mg/ml Mn0.3Fe2.7O4/SiO2 NPs increases monotonically with increasing NP size, under an AC field of 33 kA/m and 380 kHz. The temperature change T vs time curves (heating curves) are plotted in Fig. 1 (c) , where TT(t)-T0; T(t) is the temperature at time t and T0 is ambient temperature. From the heating curves, SLP vs size can be extracted using the Box-Lucas fitting known to give reliable SLP values, [36] [37] [38] [39] and plotted in Fig. 1(d) . The contribution from pure water under identical conditions was also measured and subtracted as the background. As can be seen from Fig. 1(c Since there is an upper size limit due to agglomeration, as discussed earlier, an alternative approach to enhancing SLP is to increase the effective magnetic anisotropy, while fixing the NP size to 22 nm. We realize anisotropy tuning by cobalt alloying to produce mixed ferrites CoxMn(0.3-x)Fe2.7O4. Compared to earlier reported core/shell approach, [27] cation alloying possesses distinct advantages: one pot synthesis with high reproducibility, and the ability to tune anisotropy parameters independent of size.
It is found that a small percentage of Co alloying (i.e. a moderately larger anisotropy)
is optimum for maximizing SLP. The alloy composition (x~0-0. with further increasing the Co amount. This is understood since increasing effective anisotropy increases the energy barrier for magnetization reversal, and thus the area of the AC hysteresis loop initially increases. However, with further increasing anisotropy, the field amplitude is insufficient to saturate the magnetization at the operating frequency, resulting in minor hysteresis loops with decreased area. The maximum SLP is measured to be 3417 W/gmetal for x= 0.03, which is more than 50% higher than that for the same sized Mn0.3Fe2.7O4. This value is close to the theoretical limit of SLP for ferrite NPs, with an  value of 0.49. This is higher than  = 0.39 for a random ensemble.
We suggest that the higher  not only reflects a certain degree of alignment due to dipole interactions, but also results from an effective anisotropy type close to cubic instead of uniaxial ( / = 0.62 and 0.7, for x = 0.02 and 0.03, respectively, as extracted from Fig. 2 ). We further note that for the sample with maximized SLP, the estimated room temperature anisotropy field HK is ~ 36 kA/m (see Table 1 of Supporting Information, SI), slightly higher than the applied field of 33 kA/m. In general, SLP values increase with increasing frequency and amplitude of AC fields. However, for clinical hyperthermia applications, there is a safety limit on the product of field frequency and amplitude typically taken to be Hf =510 9 A/(ms).
Anisotropy optimized to achieve maximum SLP at high fields will not be optimal for clinically relevant low fields. Fig. S5(a) shows the heating curves of 22-nm Co0.03Mn0.27Fe2.7O4/SiO2 NP aqueous dispersion (1 mgNPs/ml) under the AC field of 380 kHz with different field amplitudes. As calculated from the heating curve shown in Fig. S5 (a) (see SI), the SLP at H =13 kA/m decreases to just 266 W/g, and further decreases to 40 W/g at 7 kA/m. To achieve large SLP and ILP at fields smaller than 13
kA/m (Hf < 510 9 A/(ms)), a softer material with an anisotropy field comparable to the field amplitude is needed. For clinical applications, we resort to non-stoichiometric zinc ferrite NPs for their biocompatibility and low anisotropy. [24] It is known that the MS of zinc ferrite is highly sensitive to Zn content, with ZnFe2O4 being antiferromagnetic if Zn 2+ ions occupy the A-site of the spinel lattice only. [43] One can tune the MS and anisotropy by varying the Zn: Fe ratio. Fig. 3(a) shows the composition dependence of room temperature MS in ZnxFe3-xO4 NPs. It can be seen that MS increases first monotonically with increasing x, and reaches a maximum of 458 kA/m at x =0.3, comparable to zinc ferrite synthesized by other methods. [44] [45] [46] Achieving SLP > 1000 W/g at clinically safe field parameters is significant, since it would allow sufficient heating for targeted treatment of small tumors and metastases, at low NP concentration achievable through antibody targeting. [47] To compare with other NPs, ILP is calculated and plotted in Fig. 3(d) . ILP is 15.7 nHm 2 /kg at H = 13
kA/m, a value significantly higher than that of NPs synthesized previously. [48] As can be seen from fig. 3 [32] However, one should note that these values were obtained by aligning the NPs in an external field. Without field alignment, the obtained SLP is expected to be lower by a factor of three. [32] While the SLP increases monotonically with increasing field for both samples as seen in times that of water at room temperature. [49] The high viscosity of the glycerol solution hinders the rotation of the NPs, making Brownian motion ineffective in contributing to AC field heating. However, it is clear that the dominating contribution to hysteresis loss is the Né el relaxation, as more than 50% of the heating performance is retained for the most viscos sample. This enables high heating of NP bone cement as discussed in the following section.
Surgical resection combined with chemo-and radiotherapy has been a clinical gold standard for the treatment of bone tumors. However, the patients are more likely to experience a tumor recurrence due to the bone microenvironment-associated tumor resistance to chemo-and radiotherapy, or inadequate surgical margins. Targeted thermal therapy of bone tumors become attractive because of its high selective damage of tumor tissue and repeatability. [50] We use bone cement containing 1 wt% Zn0.3Fe2.7O4 NPs for local hyperthermia experiments. A piece of pig rib with a hole 6.0 mm in diameter and 6.0 mm in length were filled with the magnetic cement, and exposed to an AC field of 380 kHz and 13 kA/m, as shown in Fig. 4 (a) . The surrounding of the bone was watercooled at 37 C to mimic cooling by blood vessels. The temperature rise of the pig rib was recorded by both a high-resolution infrared (IR) camera and a fiber optic probe. It can be seen that the temperature of the magnetic cement rises rapidly to the therapeutic threshold required for cancer hyperthermia (T >42 °C). The center of cement reaches 50 °C within 1 minute; and the temperature of entire cement rises to above 50 °C within 3 min. When the heating time is up to 30 min, the cement is heated to 70 °C, while the region 25 mm away from the center is above 46 °C. In Fig. 4 (a) , the red dots represent the region with the temperature at the therapeutic threshold of 42 °C. With increasing exposure time, the region with temperature > 42 °C expands. After 25 min, the temperature of the entire bone is over 42 °C. As a comparison, in a previous study, [51] bone cement containing 60 wt% of magnetic materials was used to reach similar temperature change at a maximum AC field of 100 kHz and 23.9 kA/m. A significant gNPs/ml at 37.4 kA/m and 500 kHz (Hf value 1.5 times higher). [16] To test the performance of Zn0.3Fe2.7O4/SiO2 NPs, a concentration of 300 gNPs/ml were used. Cytotoxicity of different types of NPs to cells was also measured and compared.
The viability of the MEF and MG-63 cells was determined by CCK-8 assay after incubation with various concentrations of NPs (Zn0.3Fe2.7O4/SiO2, Fe3O4/SiO2, and Mn0.3Fe2.7O4/SiO2) for 24 and 48h. Cells without NPs were used as control groups. As shown in Fig. 5 , the cytotoxicity is the lowest for Zn0.3Fe2.7O4/SiO2 and highest for Co0.03Mn0.27Fe2.7O4/SiO2, with Fe3O4/SiO2 in between. In the case of Zn0.3Fe2.7O4/SiO2, up to the concentration of 1000 µg/ml, the cell viability shows no significant difference (P > 0.05) from the control groups after incubation for 24h. Though at 700 and 1000 g/ml after incubation for 48 h, viability of cells with Zn0.3Fe2.7O4/SiO2 is lower than that of control groups, it is still above 75% for MEF and above 73% for MG-63 cells.
For MEF Incubated with Fe3O4/SiO2 NPs at concentration higher than 500 g/ml at both incubation time of 24 and 48 h, cell viability is lower than that of the control sample, while Fe3O4/SiO2 shows cytotoxicity in MG-63 starting at 300 g/ml upon incubation for 48 h. As for Co0.03Mn0.27Fe2.7O4/SiO2, cytotoxicity is observed at concentration above 100 g/ml, regardless of cell lines and incubation time. At the highest concentration of 1000 g/ml and 48 h, cell viability is even as low as 9.48%. 
Silica coating of magnetic NPs
The silica shells were coated on the hydrophobic NPs via a reverse microemulsion method. [22, 32] For 4-5 nm silica coating, 20 ml cyclohexane and 1.15 ml Igepal CO-520 were mixed and 20 mg magnetic NPs in 2 ml cyclohexane were added while stirring.
0.15 ml ammonium hydroxide (28-30%) was then added, followed by 0.1 ml TEOS.
The solution was stirred at room temperature for 24 h and the resulting magnetic NPs/SiO2 core/shell NPs were precipitated by adding ethanol and centrifugation. The collected particles were washed in ethanol and water twice and precipitated by centrifugation and finally redispersed in water.
Characterizations
A Hitachi H7650 (120kV) transmission electron microscope was used to characterize the size and morphology of the NPs. Energy dispersive X-ray spectroscopy and inductively coupled plasma atomic emission spectroscopy were employed to determine the composition. The magnetic hysteresis loops were measured using a Quantum
Design Physical Property Measurement System model 6000. Hyperthermia performance of the NPs was investigated by a HYPER5 machine fabricated by MSI
Company under an AC magnetic field with frequency of 380 kHz. The temperature change of the NP solution was monitored by a fiber optic probe.
In vitro experiments
Human osteogenic sarcoma MG-63 cells and mouse fibroblast cells (MEF) were purchased from the American Type Culture Collection. MG-63 cells were plated in 35-mm culture dishes at 80% confluence (1×10 6 cells) with 2ml of DMEM/HIGH GLUCOSE medium containing 10% fetal bovine serum. The NP dispersion was added to culture dishes, and the samples were exposed to the AC magnetic field. 
Measurement of magnetic anisotropy
Saturation magnetization MS of NPs was measured by an EV-9 vibrating sample magnetometer. NPs were embedded in non-magnetic cement (purchased from Quantum Design company). The mass of organic coating on NPs was measured by thermogravimetric analysis. The net mass of NPs was used to determine the saturation magnetization. The effective magnetic anisotropy Ku was estimated from MS and HC at 10 K, using ~. HK at 300 K is estimated using the formula below to consider the thermal fluctuation of magnetic moment;  is taken to be 3 [S1] ( = 0) ( = 300 ) = [ ( = 0) ( = 300 ) ]
Measurement of solution temperature for SLP determination
The temperature of the solution was measured by a fiber optic thermometer at different locations of the vial. A schematic drawing of the measurement setup is shown in Fig. S4 (a) . The heating curves for these locations are plotted in Fig. S4 (b) . 
Extraction of SLP
For reliable extraction of SLP, all heating curves are fitted by the Box-Lucas formula ∆T = (1 − − ( − 0 ) ) [S2] with and k as the fitting parameters. is the initial slope of the heating curve, and k is a constant describing the cooling rate. SLP is then calculated as = , where is the specific heat capacity of the solution taken to be 4.184 J/(gC), and is the mass concentration of the metal in the NP solution (e.g. for Fe3O4, 1 mg NPs /ml = 0.724 mgFe/ml).
The reliability of the fitting is further verified by measuring the cooling curve directly (shown in Fig. S7(b) ), from which k can be extracted independently using ∆T = 0 + ( − 0 ) − ( − 0 ) . The difference is found to be smaller than 0.1%. 
